DCIS is a non-invasive or pre-invasive breast cancer, meaning the cancer cells are confined to the milk ducts and haven’t ...

The FDA granted breakthrough therapy designation to first-line treatment with Enhertu plus Perjeta for unresectable or metastatic HER2+ breast cancer.

A common anti-nausea drug used during chemotherapy may do more than ease discomfort, it could help women with aggressive ...

Olivia Munn is opening up about her mom's breast cancer diagnosis. The "Your Friends and Neighbors" star, 45, took to ...

Cells and tissues surrounding a breast cancer tumor may hold critical information about how patients will respond to ...

The global HER2+ gastric cancer market is experiencing significant growth, driven by the rising incidence of gastric cancer and increased healthcare investments. HER2-positive gastric cancer, ...

The latest advancements in upper gastrointestinal (GI) cancer treatment include early detection tools, immunotherapy, ...

Oncopathology or cancer pathology is a specialised branch of pathology focused on diagnosing and characterising tumours ...

OST-HER2 already holds several valuable FDA designations, including Orphan Drug, Fast Track, and Rare Pediatric Disease. If the therapy is approved before September 30, 2026, OSTX will be eligible to ...

Around 5,700 people with early breast cancer are set to benefit from expanded access to a treatment combination designed to help prevent their cancer from returning, following our recommendation, ...

After sharing her breast cancer diagnosis in 2024, Olivia Munn shared that her mother Kim Munn went through her own battle ...